A Phase II Trial of Pembrolizumab Plus Bevacizumab in Patients With Metastatic Melanoma or Non-small Cell Lung Cancer With Untreated Brain Metastases
Conditions
Brain and Nervous System | Lung | Melanoma, skin
Phase II
Volunteers
Health Professionals
What is the purpose of this trial?
The purpose of this phase 2 trial is to study the activity of pembrolizumab in combination with bevacizumab in patients with untreated brain metastases from melanoma or NSCLC to determine activity and safety of the drug combination. Furthermore, in patients who undergo resection of biopsy of a brain metastasis, we will evaluate biomarkers predictive of treatment benefit, and will also conduct correlative biomarker studies on extra-cerebral specimens in all patients in whom a systemic biopsy is feasible or in archival tumor tissue when available.
A total of 53 eligible patients will be enrolled on this trial (20 with melanoma and 33 with NSCLC). Individual cohorts of the study can be stopped if insufficient activity is observed in the first stage of that cohort. The study will accrue for approximately 24 months, and will be open for approximately 12 additional months as patients on study are being followed.
- Ages18 years and older
- GenderBoth
- Trial withYale Cancer Center
- Start Date05/26/2016
- End Date04/30/2023
For more information about this study, contact:
Neta Shanwetter Levit
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
Sub-Investigators
- Adam Boruchov, MD
- Agatha Hecht
- Alessia Donadio, MD
- Amit Mahajan, MD
- Andrea Martelli
- Anne Chiang, MD, PhD
- David Witt, MD
- Emily Duffield, APRN
- Frederick Wilson, MD, PhD
- Harold Tara Jr, MD
- James Vredenburgh, MD
- Jaykumar Thumar, MBBS, MD
- Jonathan Sporn, MD
- Joy Mullins, PA-C, MPAS
- Justin Persico, MD
- Karishma Mehra, MBBS
- Kathryn Medow, APRN
- Madeline Santiago
- Marianne Davies, NP, DNP, MSN, BSN
- Mario Sznol, MD
- Michael Cohenuram, MD
- Michael Hurwitz, PhD, MD
- Neal Fischbach, MD
- Pawan Karanam, MD
- Roy S. Herbst, MD, PhD
- Sarah Goldberg, MD, MPH
- Sarah Weiss, MD
- Scott Gettinger, MD
- Sudhanshu Mulay, MD
- Susan Rabinowe, MD
- Syed Bilgrami, MBBS
- Veronica Chiang, MD, FAANS
- Zia Rahman, MD
- Last Updated09/23/2020
- Study HIC#1512016953